Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $284,358 - $446,706
16,600 New
16,600 $342,000
Q4 2022

Feb 14, 2023

SELL
$25.44 - $59.78 $3.3 Million - $7.75 Million
-129,700 Reduced 76.43%
40,000 $1.09 Million
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $1.7 Million - $2.38 Million
-39,000 Reduced 18.69%
169,700 $9.13 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $2.11 Million - $5.66 Million
73,200 Added 54.02%
208,700 $8.42 Million
Q1 2022

May 13, 2022

BUY
$48.25 - $100.49 $6.54 Million - $13.6 Million
135,500 New
135,500 $8.97 Million
Q1 2020

May 15, 2020

SELL
$59.04 - $88.81 $1.14 Million - $1.71 Million
-19,300 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$59.49 - $82.78 $1.15 Million - $1.6 Million
19,300 New
19,300 $1.51 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.